IPOGenie Presale Surges Past $1.1M Ahead of Scheduled Price Increase
IPOGenie's presale has eclipsed $1.1 million in funding as investors flock to its AI-driven platform for tokenized private market exposure. The project, which bridges venture capital opportunities to retail participants, enters Phase 55 with a February 21 deadline before its next price adjustment.
The current token price of $0.00012390 reflects steady demand, with 10.4 billion units already sold from a 4.2 billion allocation. This staged approach creates urgency among early participants seeking advantage before incremental price hikes.
What sets IPOGenie apart is its institutional-grade framework—AI-powered evaluation tools democratize access to pre-IPO deals traditionally reserved for large funds. The platform's structured methodology contrasts sharply with speculative token launches, signaling a maturation in crypto investment vehicles.
